Bladder Cancer - Results from #200

Impact of Alzheimer's Disease and Related Dementia Diagnosis Following Treatment for Bladder Cancer - Beyond the Abstract May 21, 2020

Internal Audit of an Enhanced Recovery after Surgery Protocol for Radical Cystectomy - Beyond the Abstract May 15, 2020

Percutaneous Nephrostomy in Obstructing Pelvic Malignancy Does Not Facilitate Further Oncological Treatment - Beyond the Abstract May 14, 2020

Occult Nodal Metastases in Patients Down-Staged to Non-Muscle Invasive Disease Following Neoadjuvant Chemotherapy - Beyond the Abstract May 12, 2020

Safety and Efficacy of Intensive Instillation of Low-Dose Pirarubicin vs. Bacillus Calmette-Guérin in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer - Beyond the Abstract May 7, 2020

Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial Carcinoma - Beyond the Abstract May 6, 2020

Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer - Beyond the Abstract May 5, 2020

Detecting Invisible Bladder Cancers with Blue Light Cystoscopy - Beyond the Abstract April 27, 2020

The Role of Cancer Stem Cells in Immunotherapy for Bladder Cancer: An In Vitro Study - Beyond the Abstract April 24, 2020

Biomarkers for Predicting Benefit from Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer - Beyond the Abstract April 16, 2020

PAK4 as a Promising New Therapeutic Target in Aggressive Bladder Cancer - Beyond the Abstract April 16, 2020

Carcinogen Biomarkers in the Urine of Electronic Cigarette Users and Implications for the Development of Bladder Cancer: A Systematic Review - Beyond the Abstract April 16, 2020

Update on Bladder Preservation Therapies for Muscle-Invasive Bladder Cancer - Beyond the Abstract April 14, 2020

Port-Site Metastasis and Atypical Recurrences after Robotic-Assisted Radical Cystectomy (RARC): An Updated Comprehensive and Systematic Review of Current Evidences - Beyond the Abstract April 7, 2020

Patient-Reported Quality of Life Outcomes in Patients Treated for Muscle-Invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial - Beyond the Abstract March 26, 2020

Expression of L-Type Amino Acid Transporter 1 as a Molecular Target for Prognostic and Therapeutic Indicators in Bladder Carcinoma - Beyond the Abstract March 24, 2020

Anesthesia in Combination with Propofol Increases Disease-Free Survival in Bladder Cancer Patients Who Undergo Radical Tumor Cystectomy as Compared to Inhalational Anesthetics and Opiate-Based Analgesia - Beyond the Abstract March 20, 2020

Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions - Beyond the Abstract March 17, 2020

The Emerging Landscape of Germline Variants in Urothelial Carcinoma: Implications for Genetic Testing - Beyond the Abstract March 17, 2020

Highlighting the General Importance of Using Public Data Repositories for Hypothesis Generation and How It Changed Cancer Basic Research - Beyond the Abstract March 12, 2020

Page 11 of 24